The Evolving Face of Human Immunodeficiency Virus-Related Progressive Multifocal Leukoencephalopathy: Defining a Consensus Terminology

References

• Antinori A, A=assari A, De Luca A, Cingolani A, Murri R, Scoppettuolo G, FortiniM, Tartaglione T, Larocca LM, Zannoni G, Cattani P, Grillo R, Roselli R, Iacoangeli M, Scerrati M, Ortona L (1997). Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. Neurol-ogy 48: 687–694.
   PubMed Web of Science ®Google Scholar
• Astrom KE, Mancall EL, Richardson EP Jr (1958). Progres-sive multifocal leukoencephalopathy. Brain 81: 93–127.
   PubMed Web of Science ®Google Scholar
• Berger JR, Levy RM, Flomenhoft D, Dobbs M (1998). Predic-tive factors for prolonged survival in acquired immun-odeficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann Neurol 44: 341–349.
   Google Scholar
• Cinque P, Scarpellini P, Vago L, Linde A, Lazzarin A (1997). Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction. AIDS 11: 1–17.
   PubMed Web of Science ®Google Scholar
• Clifford DB, Yiannoutsos C, Glicksman M, Simpson DM, Singer EJ, Piliero PJ, Marra CM, Francis GS, McArthur JC, Tyler KL, Tselis AC, Hyslop NE (1999). HAART im-proves prognosis in HIV-associated progressive multifo-cal leukoencephalopathy. Neurology 52: 623–625.
   PubMed Web of Science ®Google Scholar
• Corral I, Quereda C, Hellin T, Navas E, Garcia-Villanueva M (2002). Relapsing and remitting leukoencephalopathy associated with chronic HIV infection. Eur Neurol 481: 39–41.
   Google Scholar
• De Luca A, Giancola ML, A=assari A, Grisetti S, Paglia MG, Gentile M, Cingolani A, Murri R, Liuzzi G, Monforte AD, Antinori A (2000). The effect of potent antiretro-viral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy.J Infect Dis 182: 1077–1083.
   Google Scholar
• Dörries K (2002). Human polyomavirus infection in pe-ripheral blood. Presented at the meeting Basic, Clin-ical and Epidemiologic Studies of Progressive Multi-focal Leukoencephalopathy: Implications for Therapy, July 25-26,2002, Portland, Maine.
   Google Scholar
• Dworkin MS, Wan PC, Hanson DL, Jones JL (1999). Progressive multifocal leukoencephalopathy: improved survival of human immunodeficiency virus-infected pa-tients in the protease inhibitor era. /Infect Dis 180: 621–625.
   PubMed Web of Science ®Google Scholar
• Eggers C, Stellbrink HJ, Buhk T, Dorries K (1999). Quantifi-cation of JC virus DNA in the cerebrospinal fluid of pa-tients with human immunodeficiency virus-associated progressive multifocal leukoencephalopathy—a longi-tudinal study. J Infect Dis 180: 1690–1694.
   Google Scholar
• Ferrante P, Omodeo-Zorini E, Caldarelli-Stefano R, Mediati M, Fainardi E, Granieri E, Caputo D (1998). Detection of JC virus DNA in cerebrospinal fluid from multiple sclerosis patients. Mult Scler 4: 49–54.
   PubMed Web of Science ®Google Scholar
• Garcia de Viedma D, Alonso R, Miralles P, Berenguer J, Rodriguez-Creixems M, Bouza E (1999). Dual qualitative-quantitative nested PCR for detection of JC virus in cerebrospinal fluid: high potential for evaluation and monitoring of progressive multifocal leukoencephalopathy in AIDS patients receiving highly active antiretroviral therapy. J Clin Microbic)] 37: 724–728.
   Google Scholar
• Gasnault J, Kousignian P, Kahraman M, Rahoiljaon J, Matheron S, Delfraissy JF, Taoufik Y (2001). Cidofovir in AIDS-associated progressive multifocal leukoen-cephalopathy: a monocenter observational study with clinical and JC virus load monitoring. J Neurovirol 7: 375–381.
   PubMed Web of Science ®Google Scholar
• Geschwind MD, Skolasky RI, Royal WS, McArthur JC (2001). The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoen-cephalopathy in AIDS. J NeuroVirol 7: 353–357.
   PubMed Web of Science ®Google Scholar
• Giudici B, Vaz B, Bossolasco S, Casari S, Brambilla AM, Luke W, Lazzarin A, Weber T, Cinque P (2000). Highly active antiretroviral therapy and progressive multifo-cal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. UM Infect Dis 30: 95–99.
   PubMed Web of Science ®Google Scholar
• Hall CD, Dafni U, Simpson D, Clifford D, Wetherill PE, Cohen B, McArthur J, Hollander H, Yainnoutsos C, Major E, Millar L, Timpone J (1998). Failure of cytara-bine in progressive multifocal leukoencephalopathy as-sociated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team. NEng/JMed 338: 1345–1351.
   Google Scholar
• Hallervorden J (1930). Eigennartige und nicht rubriziebare Prozesse. In: Handbuch der Geiteskranheiten, vol 2. Die anatomie der Psychosen. Bumke 0 (ed). Springer, Berlin, pp 1063–1107.
   Google Scholar
• Holloway RG, Mushlin Al (1996). Intracranial mass lesions in acquired immunodeficiency syndrome: using deci-sion analysis to determine the effectiveness of stereo-tactic brain biopsy. Neurology 46: 1010–1015.
   Google Scholar
• Koralnik IJ, Du Pasquier RA, Kuroda MJ, Schmitz JE, Dang X, Zheng Y, Lifton M, Letvin NL (2002). Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response spe-cific for a commonly recognized JC virus epitope. J Im-munol 168: 499–504.
   PubMed Web of Science ®Google Scholar
• Kurtzke JF (1983). Rating neurologic impairment in multi-ple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444–1452.
   PubMed Web of Science ®Google Scholar
• Levy RM, Russell E, Yungbluth M, Hidvegi DF, Brody BA, Dal Canto MC (1992). The efficacy of image-guided stereotactic brain biopsy in neurologically symptomatic acquired immunodeficiency syndrome patients. Neuro-surgery 30: 186–189; discussion, 189–190.
   Google Scholar
• Marra CM, Rajicic N, Barker DE, Cohen BA, Clifford D, Donovan Post MJ, Ruiz A, Bowen BC, Huang ML, Queen- Baker J, Andersen J, Kelly S, Shriver S (2002). A pilot study of cidofovir for progressive multifocal leukoen-cephalopathy in AIDS. AIDS 16: 1791–1797.
   PubMed Web of Science ®Google Scholar
• Padgett BL, ZuRhein GM, Walker D, Echroade R, Dessel B (1971). Cultivation of papova-like virus from human barin with progressive multifocal leukoencephalopathy. Lancet 1: 1257–1260.
   PubMed Web of Science ®Google Scholar
• Price RW, Nielsen S, Horten B, Rubino M, Padgett B, Walker D (1983). Progressive multifocal leukoencephalopathy: a burnt-out case. Ann Neurol 13: 485–490.
   Google Scholar
• Silverman L, Rubinstein LJ (1965). Electron microscopic observations on case of progressive multifocal leukoen-cephalopathy. Acta Neuropathol (Berl) 5: 215–224.
   PubMedGoogle Scholar
• Sweeney BJ, Manji H, Miller RF, Harrison MJ, Gray F, Scaravilli F (1994). Cortical and subcortical JC virus in-fection: two unusual cases of AIDS associated progres-sive multifocal leukoencephalopathy. J Neurol Neuro-surg Psychiatry 57: 994–997.
   Google Scholar
• Tassie JM, Gasnault J, Bentata M, Deloumeaux J, Boue F, Billaud E, Costagliola D (1999). Survival improve-ment of AIDS-related progressive multifocal leukoen-cephalopathy in the era of protease inhibitors. Clinical Epidemiology Group. French Hospital Database on HIV. AIDS 13: 1881–1887.
   Google Scholar
• Thumher MM, Post MJ, Rieger A, Kleibl-Popov C, Loewe C, Schindler E (2001). Initial and follow-up MR imag-ing findings in AIDS-related progressive multifocal leukoencephalopathy treated with highly active an-tiretroviral therapy. AJNR Am J Neuromdiol 22: 977–984.
   Google Scholar
• Vinters HV, Tomiyasu U, Anders KH (1989). Neuropatho-logic complications of infection with the human im-munodeficiency virus (HIV). Prog AIDS Pathol 1: 101–130.
   Google Scholar
• Weber T, Klapper PE, Cleator GM, Bodemer M, Luke W, Knowles W, Cinque P, Van Loon AM, Grandien M, Ha=arin AL, Ciardi M, Bogdanovic G (1997). Poly-merase chain reaction for detection of JC virus DNA in cerebrospinal fluid: a quality control study. European Union Concerted Action on Viral Meningitis and En-cephalitis. J Virol Methods 69: 231–237.
   Google Scholar
• Yiannoutsos CT, Major E0, Curman B, Jensen PN, Gravell M, Hou J, Clifford DB, Hall CD (1999). Relation of JC virus DNA in the cerebrospinal fluid to sur-vival in acquired immunodeficiency syndrome patients with biopsy-proven progressive multifocal leukoen-cephalopathy. Ann Neurol 45: 816–820.
   PubMed Web of Science ®Google Scholar
• ZuRhein GM, Chou SM (1965). Particles resembling paopvavirus in human cerebral demyelinating disease. Science 148: 1477–1479.
   PubMed Web of Science ®Google Scholar